Clinical Trials
All Clinical Trials - Page 32 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02758431N/ACompleted
Cardiovascular Outcomes of Low Testosterone
Gonadorelin
- NCT02806414Phase 1/Phase 2Completed
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Ll-37
- NCT02783196N/AUnknown
Effect of Liraglutide on Clock Genes
Liraglutide
- NCT02975297Phase 1/Phase 2Completed
Exenatide Once Weekly for Smoking Cessation
Exenatide
- NCT02330770Phase 4Unknown
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
Gonadorelin
- NCT05762744Phase 1Terminated
Pharmacogenomics of GLP1 Receptor Agonists
Exenatide
- NCT03017768N/ACompleted
The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers
KPV
- NCT02736591Phase 3Unknown
Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
Sermorelin
- NCT02788747Phase 2Completed
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
Elamipretide
- NCT03018314N/ACompleted
Serum Kisspeptin Levels in Infertile Women
Kisspeptin
- NCT02535299Phase 4Unknown
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Liraglutide
- NCT02718950Phase 3Unknown
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
Liraglutide
- NCT02811484Phase 4Withdrawn
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Exenatide
- NCT02773368Phase 3Completed
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT03703778N/AActive Not Recruiting
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
Gonadorelin
- NCT02686177Phase 4Completed
Effect of GLP-1 on Angiogenesis
Liraglutide
- NCT02773355N/ACompleted
Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
Liraglutide
- NCT02759107Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
Tirzepatide
- NCT02778919Phase 2Completed
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
Gonadorelin
- NCT02787447Phase 2Unknown
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
Thymosin-Alpha-1
- NCT02488057Phase 4Completed
Improving Beta Cell Function in Mexican American Women With Prediabetes
Liraglutide
- NCT02754817N/ACompleted
A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
Liraglutide
- NCT02663908Phase 3Terminated
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Gonadorelin
- NCT02624973Phase 2Active Not Recruiting
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Gonadorelin
- NCT02690883Phase 4Completed
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Exenatide
- NCT03182192Phase 1Unknown
GLP1R-imaging in Hypoglycemia
Exenatide
- NCT04112875N/ACompleted
Effect of L-arginine on Microcirculation, Myogenesis and Angiogenesis Associated With Aging, Sarcopenia and Diabetes
Follistatin
- NCT02689921Phase 2Unknown
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
Gonadorelin
- NCT02594072N/AUnknown
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)
Gonadorelin
- NCT02883595Phase 4Completed
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
Thymosin-Alpha-1
- NCT02914158Phase 3Unknown
Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
Gonadorelin
- NCT02730377Phase 4Completed
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
Liraglutide
- NCT02635386Phase 3Completed
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Exenatide
- NCT02717858Phase 1Completed
A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
Liraglutide
- NCT02696148Phase 1Completed
A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
Liraglutide
- NCT02677896Phase 3Completed
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Gonadorelin
- NCT02777073N/ACompleted
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
Liraglutide
- NCT02693119Phase 2Completed
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy
Elamipretide
- NCT02703584Phase 4Completed
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
Gonadorelin
- NCT02532400Phase 3Terminated
Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
Gonadorelin
- NCT02908087Phase 2Completed
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
Liraglutide
- NCT02898506Phase 2Completed
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
Liraglutide
- NCT02770885Phase 2Completed
Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
Dulaglutide
- NCT02664441Phase 3Completed
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Exenatide
- NCT02404376Phase 3Completed
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Exenatide
- NCT02607865Phase 3Completed
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
Semaglutide
- NCT02653391Phase 1/Phase 2Completed
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
Elamipretide
- NCT02138591Phase 3Withdrawn
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Ll-37
- NCT02673632N/AUnknown
The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS
Gonadorelin
- NCT02655770Phase 4Completed
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
Liraglutide